We've found
52,953 Cancer
clinical trials
Intraductal Papillary Mucinous Neoplasm Clinical Trial
Positron Emission Tomography-computed Tomography (PET-CT) for Main & Branch Intraductal Papillary Mucinous Neoplasm
Status: Enrolling
Updated: 7/1/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer
Status: Enrolling
Updated: 2/22/2011
Click here to add this to my saved trials
Oncology Clinical Trial
Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer
Status: Enrolling
Updated: 2/22/2011
Click here to add this to my saved trials
Oncology Clinical Trial
Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer
Status: Enrolling
Updated: 2/22/2011
Click here to add this to my saved trials
Oncology Clinical Trial
Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer
Status: Enrolling
Updated: 2/22/2011
Click here to add this to my saved trials
Oncology Clinical Trial
Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer
Status: Enrolling
Updated: 2/22/2011
Click here to add this to my saved trials
Oncology Clinical Trial
Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer
Status: Enrolling
Updated: 2/22/2011
Click here to add this to my saved trials
Oncology Clinical Trial
Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer
Status: Enrolling
Updated: 2/22/2011
Click here to add this to my saved trials
Superficial Basal Cell Carcinoma Clinical Trial
Cure Rates of Superficial Basal Cell Carcinom (BCC) Following 1 Versus 3 Cycles of Electrodessication and Curettage (ED&C)
Status: Enrolling
Updated: 11/7/2011
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Guided Biopsy for Mapping Prostate Cancer
Status: Enrolling
Updated: 9/9/2013
Click here to add this to my saved trials
Cholangiocarcinoma Clinical Trial
A Study of Gemcitabine, Capecitabine and Bevacizumab to Treat Cancer of the Gall Bladder or Bile Ducts
Status: Enrolling
Updated: 6/28/2012
Click here to add this to my saved trials
Oncology Clinical Trial
Electronic Brachytherapy for the Treatment of NMSC
Status: Enrolling
Updated: 7/17/2015
Click here to add this to my saved trials
Colorectal Cancer Clinical Trial
Personal Electronic Health Records in Improving Screening Rates for Colorectal Cancer
Status: Enrolling
Updated: 12/17/2013
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
RCT of Fixed vs Titrated Letrozole in Breast Cancer Patient Undergoing IVF
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Genetic and Environmental Risk Factors Related to Esophageal Cancer
Status: Enrolling
Updated: 9/30/2015
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Genetic and Environmental Risk Factors Related to Esophageal Cancer
Status: Enrolling
Updated: 9/30/2015
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Tumors Clinical Trial
Proton Radiotherapy for Recurrent Tumors
Status: Enrolling,
Phase
I, II
Updated: 1/26/2016
Click here to add this to my saved trials
Cancer Clinical Trial
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer
Status: Enrolling
Updated: 8/28/2013
Click here to add this to my saved trials
Cancer Clinical Trial
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer
Status: Enrolling
Updated: 8/28/2013
Click here to add this to my saved trials
Cancer Clinical Trial
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer
Status: Enrolling
Updated: 8/28/2013
Click here to add this to my saved trials
Cancer Clinical Trial
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer
Status: Enrolling
Updated: 8/28/2013
Click here to add this to my saved trials
Cancer Clinical Trial
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer
Status: Enrolling
Updated: 8/28/2013
Click here to add this to my saved trials
Cancer Clinical Trial
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer
Status: Enrolling
Updated: 8/28/2013
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Ethnic Differences in the Impact of Breast Cancer on Employment Status, Financial Situation, and Quality of Life
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology, Psychiatry / Psychology Clinical Trial
Registry of Older Patients With Cancer
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology, Psychiatry / Psychology Clinical Trial
Registry of Older Patients With Cancer
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Unspecified Childhood Solid Tumor, Protocol Specific Clinical Trial
Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Unspecified Childhood Solid Tumor, Protocol Specific Clinical Trial
Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Unspecified Childhood Solid Tumor, Protocol Specific Clinical Trial
Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Carcinoma, Hepatocellular Clinical Trial
Proton Beam Radiotherapy Plus Sorafenib Versus Sorafenib for Patients With Hepatocellular Carcinoma Exceeding San Francisco Criteria
Status: Enrolling
Updated: 11/2/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Study of the Effect of Innate on the Inflammatory Response to Endotoxin
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Rectal Cancer Clinical Trial
Intensity Modulated Radiation Therapy (IMRT) for Patients With Rectal Cancer
Status: Enrolling
Updated: 8/17/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
RO4929097 And Exemestane in Treating Pre- and Postmenopausal Patients With Advanced or Metastatic Breast Cancer
Status: Enrolling
Updated: 11/10/2011
Click here to add this to my saved trials
Her2 Negative Breast Cancer Patients Clinical Trial
Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer
Status: Enrolling
Updated: 3/1/2013
Click here to add this to my saved trials
Her2 Negative Breast Cancer Patients Clinical Trial
Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer
Status: Enrolling
Updated: 3/1/2013
Click here to add this to my saved trials
Her2 Negative Breast Cancer Patients Clinical Trial
Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer
Status: Enrolling
Updated: 3/1/2013
Click here to add this to my saved trials
Her2 Negative Breast Cancer Patients Clinical Trial
Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer
Status: Enrolling
Updated: 3/1/2013
Click here to add this to my saved trials
Her2 Negative Breast Cancer Patients Clinical Trial
Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer
Status: Enrolling
Updated: 3/1/2013
Click here to add this to my saved trials
Her2 Negative Breast Cancer Patients Clinical Trial
Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer
Status: Enrolling
Updated: 3/1/2013
Click here to add this to my saved trials
Her2 Negative Breast Cancer Patients Clinical Trial
Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer
Status: Enrolling
Updated: 3/1/2013
Click here to add this to my saved trials
We've found
52,953 Cancer
clinical trials
Intraductal Papillary Mucinous Neoplasm Clinical Trial
Updated: 7/1/2014
Positron Emission Tomography-computed Tomography (PET-CT) for Main & Branch Intraductal Papillary Mucinous Neoplasm
Status: Enrolling
Updated: 7/1/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 2/22/2011
Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer
Status: Enrolling
Updated: 2/22/2011
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 2/22/2011
Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer
Status: Enrolling
Updated: 2/22/2011
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 2/22/2011
Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer
Status: Enrolling
Updated: 2/22/2011
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 2/22/2011
Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer
Status: Enrolling
Updated: 2/22/2011
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 2/22/2011
Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer
Status: Enrolling
Updated: 2/22/2011
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 2/22/2011
Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer
Status: Enrolling
Updated: 2/22/2011
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 2/22/2011
Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer
Status: Enrolling
Updated: 2/22/2011
Click here to add this to my saved trials
Superficial Basal Cell Carcinoma Clinical Trial
Updated: 11/7/2011
Cure Rates of Superficial Basal Cell Carcinom (BCC) Following 1 Versus 3 Cycles of Electrodessication and Curettage (ED&C)
Status: Enrolling
Updated: 11/7/2011
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 9/9/2013
Guided Biopsy for Mapping Prostate Cancer
Status: Enrolling
Updated: 9/9/2013
Click here to add this to my saved trials
Cholangiocarcinoma Clinical Trial
Updated: 6/28/2012
A Study of Gemcitabine, Capecitabine and Bevacizumab to Treat Cancer of the Gall Bladder or Bile Ducts
Status: Enrolling
Updated: 6/28/2012
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 7/17/2015
Electronic Brachytherapy for the Treatment of NMSC
Status: Enrolling
Updated: 7/17/2015
Click here to add this to my saved trials
Colorectal Cancer Clinical Trial
Updated: 12/17/2013
Personal Electronic Health Records in Improving Screening Rates for Colorectal Cancer
Status: Enrolling
Updated: 12/17/2013
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
Updated: 12/31/1969
RCT of Fixed vs Titrated Letrozole in Breast Cancer Patient Undergoing IVF
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 9/30/2015
Genetic and Environmental Risk Factors Related to Esophageal Cancer
Status: Enrolling
Updated: 9/30/2015
Click here to add this to my saved trials
Esophageal Cancer Clinical Trial
Updated: 9/30/2015
Genetic and Environmental Risk Factors Related to Esophageal Cancer
Status: Enrolling
Updated: 9/30/2015
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/6/2012
Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/6/2012
Click here to add this to my saved trials
Tumors Clinical Trial
Updated: 1/26/2016
Proton Radiotherapy for Recurrent Tumors
Status: Enrolling,
Phase
I, II
Updated: 1/26/2016
Click here to add this to my saved trials
Cancer Clinical Trial
Updated: 8/28/2013
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer
Status: Enrolling
Updated: 8/28/2013
Click here to add this to my saved trials
Cancer Clinical Trial
Updated: 8/28/2013
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer
Status: Enrolling
Updated: 8/28/2013
Click here to add this to my saved trials
Cancer Clinical Trial
Updated: 8/28/2013
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer
Status: Enrolling
Updated: 8/28/2013
Click here to add this to my saved trials
Cancer Clinical Trial
Updated: 8/28/2013
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer
Status: Enrolling
Updated: 8/28/2013
Click here to add this to my saved trials
Cancer Clinical Trial
Updated: 8/28/2013
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer
Status: Enrolling
Updated: 8/28/2013
Click here to add this to my saved trials
Cancer Clinical Trial
Updated: 8/28/2013
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer
Status: Enrolling
Updated: 8/28/2013
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 12/31/1969
Ethnic Differences in the Impact of Breast Cancer on Employment Status, Financial Situation, and Quality of Life
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology, Psychiatry / Psychology Clinical Trial
Updated: 12/31/1969
Registry of Older Patients With Cancer
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology, Psychiatry / Psychology Clinical Trial
Updated: 12/31/1969
Registry of Older Patients With Cancer
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Unspecified Childhood Solid Tumor, Protocol Specific Clinical Trial
Updated: 8/1/2013
Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Unspecified Childhood Solid Tumor, Protocol Specific Clinical Trial
Updated: 8/1/2013
Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Unspecified Childhood Solid Tumor, Protocol Specific Clinical Trial
Updated: 8/1/2013
Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Status: Enrolling
Updated: 8/1/2013
Click here to add this to my saved trials
Carcinoma, Hepatocellular Clinical Trial
Updated: 11/2/2016
Proton Beam Radiotherapy Plus Sorafenib Versus Sorafenib for Patients With Hepatocellular Carcinoma Exceeding San Francisco Criteria
Status: Enrolling
Updated: 11/2/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Study of the Effect of Innate on the Inflammatory Response to Endotoxin
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Rectal Cancer Clinical Trial
Updated: 8/17/2012
Intensity Modulated Radiation Therapy (IMRT) for Patients With Rectal Cancer
Status: Enrolling
Updated: 8/17/2012
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 11/10/2011
RO4929097 And Exemestane in Treating Pre- and Postmenopausal Patients With Advanced or Metastatic Breast Cancer
Status: Enrolling
Updated: 11/10/2011
Click here to add this to my saved trials
Her2 Negative Breast Cancer Patients Clinical Trial
Updated: 3/1/2013
Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer
Status: Enrolling
Updated: 3/1/2013
Click here to add this to my saved trials
Her2 Negative Breast Cancer Patients Clinical Trial
Updated: 3/1/2013
Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer
Status: Enrolling
Updated: 3/1/2013
Click here to add this to my saved trials
Her2 Negative Breast Cancer Patients Clinical Trial
Updated: 3/1/2013
Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer
Status: Enrolling
Updated: 3/1/2013
Click here to add this to my saved trials
Her2 Negative Breast Cancer Patients Clinical Trial
Updated: 3/1/2013
Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer
Status: Enrolling
Updated: 3/1/2013
Click here to add this to my saved trials
Her2 Negative Breast Cancer Patients Clinical Trial
Updated: 3/1/2013
Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer
Status: Enrolling
Updated: 3/1/2013
Click here to add this to my saved trials
Her2 Negative Breast Cancer Patients Clinical Trial
Updated: 3/1/2013
Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer
Status: Enrolling
Updated: 3/1/2013
Click here to add this to my saved trials
Her2 Negative Breast Cancer Patients Clinical Trial
Updated: 3/1/2013
Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer
Status: Enrolling
Updated: 3/1/2013
Click here to add this to my saved trials